Predictive Oncology Inc (POAI)
0.828
+0.06
(+7.53%)
USD |
NASDAQ |
Nov 07, 16:00
0.793
-0.04
(-4.23%)
After-Hours: 20:00
Predictive Oncology Revenue (Annual): 1.780M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.780M |
| December 31, 2022 | 1.506M |
| December 31, 2021 | 1.421M |
| December 31, 2020 | 1.252M |
| December 31, 2019 | 1.412M |
| December 31, 2018 | 1.412M |
| December 31, 2017 | 0.6548M |
| December 31, 2016 | 0.4565M |
| Date | Value |
|---|---|
| December 31, 2015 | 0.6544M |
| December 31, 2014 | 0.9516M |
| December 31, 2013 | 0.4681M |
| December 31, 2012 | 0.1888M |
| December 31, 2011 | 0.0966M |
| December 31, 2010 | 0.0003M |
| December 31, 2009 | 0.0157M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.252M
Minimum
2020
1.780M
Maximum
2023
1.474M
Average
1.421M
Median
2021
Revenue (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 43.60M |
| InfuSystems Holdings Inc | 125.78M |
| Xtant Medical Holdings Inc | 91.30M |
| Catheter Precision Inc | 0.442M |